Anavex Life Sciences Corp (AVXL)

[nidan7500]

By my count, this happened about 100 years (+/-) too late to save whatever is left of the FDA.

@adamfeuerstein
·
Follow
EXCLUSIVE --> Biogen’s $BIIB Samantha Budd Haeberlein, an architect of Aduhelm, leaves company https://statnews.com/2023/03/12/biogen-samantha-budd-haeberlein-leaves-company-aduhelm/

Her departure comes two weeks after Billy Dunn left the FDA.
statnews.com
Biogen's Samantha Budd Haeberlein, an architect of Aduhelm, leaves company
Samantha Budd Haeberlein, the Biogen senior executive who supervised the development and controversial approval of the Alzheimer’s treatment Aduhelm, has left the company, STAT has learned.
12:01 PM · Mar 12, 2023